The leading medical technology company Siemens Healthineers plans to invest $188 million over the next five years in an innovation hub in Bengaluru, India. The company plans to create up to 1,800 digital talents in the next ten years.
- The innovation hub will be housed in a new state-of-the-art campus that combines the existing R&D center and an ultra-modern medical imaging factory.
- The investment aims to make India a manufacturing center for the companys emerging market products.
- Siemens Healthineers plans to expand its product portfolio to address the challenge of affordability that is specific to these markets.
In August 2020, Siemens Healthineers AG announced an agreement to acquire all shares of California based Varian Medical Systems for approximately USD 16.4 billion. Varian is a leading medical device and software maker.
In July 2020, Bayer and Siemens Healthineers presented the new Imaging System Interface (ISI) for magnetic resonance imaging (MRI). ISI is a joint hardware and software development from Bayer and Siemens Healthineers and the first injector scanner interface for the MRI suite.
In April 2020, Siemens Healthineers announced the ecpansion of its infectious disease testing capabilities to aid in the COVID-19 pandemic. Recognizing the critical need for accurate diagnostic testing to manage COVID-19, the company has developed a laboratory-based total antibody test1 to detect the presence of SARS-CoV-2 antibodies in blood.
About Siemens Healthineers
Siemens Healthineers, headquartered in Palo Alto, California, United States, is a global medical technology company. The company provides innovative technologies and services in the areas of diagnostic and therapeutic imaging, laboratory diagnostics and molecular medicine as well as digital health and enterprise services across the globe. The company has more than 50,000 employees in around 70 countries.